Imfinzi

Durvalumab

6.5 Moderate risk

Imfinzi & Radiation pneumonitis

19.9%

of users reported Radiation pneumonitis

45.7%

also reported Severe reaction

79.3%

are men

Most common medical consequences

Severe reaction
45.7%
Hospitalization
44.4%
Death
7.0%
Disability
1.9%
Life-threatening condition
1.1%

Have you experienced any negative side effects from this medication?

Imfinzi: general information

Most common side effects (72)

Most commonly affected ages

40 - 49 years
2.4%
50 - 59 years
13.8%
60 - 69 years
36.5%
70 - 79 years
38.5%
80 - 89 years
8.8%